still not too late to jump on this! - NZ scientist - great phase two results for Phelan McDermid- three other phase two trials due in 2024- touched $22 today.
Printable View
still not too late to jump on this! - NZ scientist - great phase two results for Phelan McDermid- three other phase two trials due in 2024- touched $22 today.
Found I bought 6000 shares for 9 cents in 2013. And then sold them again not that long after sadly
Another home run for Neuren- Pitt Hopkins ph 2 topline results- statistically significant improvement. Back over 3 billion -$24 per share. Angleman in July, and mouse models on other indications- so a big pipeline which will be very attractive to BP.
https://www.youtube.com/watch?v=hWEzs-MX1qc